Inventor
BARROW JAMES C
US32 patents
⚠️ This page may combine multiple inventors who share the name “BARROW JAMES C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
12 patentsUS6403612B2Jun 11, 2002
Thrombin receptor antagonists
MERCK & CO INC9 citations74
US6515011B2Feb 4, 2003
Thrombin inhibitors
MERCK & CO INC11 citations72
US6534510B2Mar 18, 2003
Thrombin inhibitors
MERCK & CO INC8 citations71
US6544982B1Apr 8, 2003
Thrombin receptor antagonists
MERCK & CO INC5 citations63
US7144899B2Dec 5, 2006
Thrombin inhibitors
MERCK & CO INC5 citations62
US6610701B2Aug 26, 2003
Thrombin inhibitors
MERCK & CO INC5 citations60
US6515023B2Feb 4, 2003
Thrombin receptor antagonists
MERCK & CO INC6 citations60
US6462050B1Oct 8, 2002
Thrombin inhibitors
MERCK & CO INC4 citations57
US7550481B2Jun 23, 2009
Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's disease
MERCK & CO INC2 citations52
US7084134B2Aug 1, 2006
Thrombin inhibitors
MERCK & CO INC0 citations52
US6339090B1Jan 15, 2002
Alpha 1A adrenergic receptor antagonists
MERCK & CO INC1 citations52
US6235759B1May 22, 2001
Dihydropyridinones and pyrrolinones useful as alpha 1A adrenoceptor antagonists
MERCK & CO INC0 citations34
MERCK SHARP & DOHME
7 patentsUS7875636B2Jan 25, 2011
Pyridyl amide T-type calcium channel antagonists
MERCK SHARP & DOHME18 citations91
US7745452B2Jun 29, 2010
Quinazolinone T-type calcium channel antagonists
MERCK SHARP & DOHME4 citations58
US8003653B2Aug 23, 2011
Imidazolidinone compounds useful as β-secretase inhibitors for the treatment of Alzheimer's disease
MERCK SHARP & DOHME4 citations56
US9399651B2Jul 26, 2016
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
MERCK SHARP & DOHME0 citations48
US7968571B2Jun 28, 2011
2,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's Disease
MERCK SHARP & DOHME0 citations41
US9266881B2Feb 23, 2016
Triazolopyridinone PDE10 inhibitors
MERCK SHARP & DOHME0 citations36
US9260413B2Feb 16, 2016
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
MERCK SHARP & DOHME0 citations34
BARROW JAMES C
6 patentsUS8263627B2Sep 11, 2012
Pyridyl amide T-type calcium channel antagonists
BARROW JAMES C33 citations90
US8637513B2Jan 28, 2014
Heterocycle phenyl amide T-type calcium channel antagonists
BARROW JAMES C4 citations70
US8530483B2Sep 10, 2013
Substituted azabenzoxazoles
BARROW JAMES C4 citations57
US8389720B2Mar 5, 2013
Quinolone neuropeptide S receptor antagonists
BARROW JAMES C1 citations49
US8501773B2Aug 6, 2013
4-fluoro-piperidine T-type calcium channel antagonists
BARROW JAMES C1 citations48
US8114887B2Feb 14, 2012
Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
BARROW JAMES C0 citations38
WOLKENBERG SCOTT
3 patentsUS9309199B2Apr 12, 2016
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
WOLKENBERG SCOTT1 citations48
US9024032B2May 5, 2015
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
WOLKENBERG SCOTT1 citations45
US8969364B2Mar 3, 2015
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
WOLKENBERG SCOTT0 citations35